BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mezmale L, Coelho LG, Bordin D, Leja M. Review: Epidemiology of Helicobacter pylori. Helicobacter 2020;25 Suppl 1:e12734. [PMID: 32918344 DOI: 10.1111/hel.12734] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Bordin DS, Voynovan IN, Andreev DN, Maev IV. Current Helicobacter pylori Diagnostics. Diagnostics (Basel) 2021;11:1458. [PMID: 34441392 DOI: 10.3390/diagnostics11081458] [Reference Citation Analysis]
2 Jonaityte IR, Ciupkeviciene E, Jonaitis P, Kupcinskas J, Petkeviciene J, Jonaitis L. Changes in the Seroprevalence of Helicobacter pylori among the Lithuanian Medical Students over the Last 25 Years and Its Relation to Dyspeptic Symptoms. Medicina (Kaunas) 2021;57:254. [PMID: 33803389 DOI: 10.3390/medicina57030254] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Öztekin M, Yılmaz B, Ağagündüz D, Capasso R. Overview of Helicobacter pylori Infection: Clinical Features, Treatment, and Nutritional Aspects. Diseases 2021;9:66. [PMID: 34698140 DOI: 10.3390/diseases9040066] [Reference Citation Analysis]
4 Zheng W, Zhu Z, Ying J, Long G, Chen B, Peng K, Li F, Zhao H, Jiang M. The Effects of Helicobacter pylori Infection on Gastric Microbiota in Children With Duodenal Ulcer. Front Microbiol 2022;13:853184. [PMID: 35547124 DOI: 10.3389/fmicb.2022.853184] [Reference Citation Analysis]
5 Komarov AL, Shahmatova OO, Korobkova VV, Kurilina EV, Shuleshova AG, Panchenko EP. Gastric mucosa condition in patients with coronary artery disease and high risk of gastrointestinal bleeding (register REGATTA-1). Terapevticheskii arkhiv 2022;93:1457-62. [DOI: 10.26442/00403660.2021.12.201224] [Reference Citation Analysis]
6 Eletto D, Mentucci F, Voli A, Petrella A, Porta A, Tosco A. Helicobacter pylori Pathogen-Associated Molecular Patterns: Friends or Foes? Int J Mol Sci 2022;23:3531. [PMID: 35408892 DOI: 10.3390/ijms23073531] [Reference Citation Analysis]
7 Caballero-plasencia M, Caballero-mateos A, Caballero-plasencia A. Inflammatory map of the gastroduodenal mucosa in patients with upper gastrointestinal symptoms. The role of H. pylori infection. Revista de Gastroenterología de México (English Edition) 2022. [DOI: 10.1016/j.rgmxen.2022.03.009] [Reference Citation Analysis]
8 Wang K, Lou D, Dai W, Fu R, Ma Z. Comparison of sequential therapy with concomitant therapy in first-line treatment of Helicobacter pylori: an updated meta-analysis. J Med Microbiol 2022;71. [PMID: 35041577 DOI: 10.1099/jmm.0.001490] [Reference Citation Analysis]
9 Ferreira R, Sousa C, Gonçalves RFS, Pinheiro AC, Oleastro M, Wagemans J, Lavigne R, Figueiredo C, Azeredo J, Melo LDR. Characterization and Genomic Analysis of a New Phage Infecting Helicobacter pylori. Int J Mol Sci 2022;23:7885. [PMID: 35887231 DOI: 10.3390/ijms23147885] [Reference Citation Analysis]
10 Zahmatkesh ME, Jahanbakhsh M, Hoseini N, Shegefti S, Peymani A, Dabin H, Samimi R, Bolori S. Effects of Exosomes Derived From Helicobacter pylori Outer Membrane Vesicle-Infected Hepatocytes on Hepatic Stellate Cell Activation and Liver Fibrosis Induction. Front Cell Infect Microbiol 2022;12:857570. [DOI: 10.3389/fcimb.2022.857570] [Reference Citation Analysis]
11 Jonaitis P, Kupcinskas J, Nyssen OP, Puig I, Gisbert JP, Jonaitis L. Evaluation of the Effectiveness of Helicobacter pylori Eradication Regimens in Lithuania during the Years 2013-2020: Data from the European Registry on Helicobacter pylori Management (Hp-EuReg). Medicina (Kaunas) 2021;57:642. [PMID: 34201428 DOI: 10.3390/medicina57070642] [Reference Citation Analysis]